How Intragenic LINE-1 Affects Gene Expression in Cancer Cells
Author Information
Author(s): Aporntewan Chatchawit, Phokaew Chureerat, Piriyapongsa Jittima, Ngamphiw Chumpol, Ittiwut Chupong, Tongsima Sissades, Mutirangura Apiwat
Primary Institution: Chulalongkorn University
Hypothesis
Thousands of genes may be regulated by intragenic L1 hypomethylation in cancerous cells.
Conclusion
Intragenic L1 hypomethylation represses gene expression in cancer cells through the action of AGO2.
Supporting Evidence
- Intragenic L1 sequences have been conserved across evolutionary time.
- The odds ratio of down-regulated genes between demethylated normal bronchial epithelium and lung cancer was high.
- Comprehensive analysis showed that expression of genes containing L1s had a significantly higher likelihood to be repressed in cancer.
Takeaway
In cancer, certain DNA elements called L1s can turn off genes, making it harder for cells to function normally. This happens because these L1s lose their protective coating, which usually keeps them quiet.
Methodology
The study involved analyzing gene expression data from cancer and normal cells, comparing mRNA levels, and performing statistical tests to evaluate the influence of intragenic L1s on gene expression.
Potential Biases
Potential biases may arise from the selection of gene expression datasets and the interpretation of statistical results.
Limitations
Not all intragenic L1s can repress gene expression in cancer, and their regulatory mechanisms may vary.
Participant Demographics
The study analyzed data from various cancer types, including head and neck squamous cell carcinoma, cervical cancer, and lung cancer.
Statistical Information
P-Value
p<1E−27
Confidence Interval
95% CI = 2.54–3.88
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website